Hydrogels used for cell-based drug delivery.

Stem cells, progenitor cells, and lineage-committed cells are being considered as a new generation of drug depots for the sustained release of therapeutic biomolecules. Hydrogels are often used in conjunction with the therapeutic secreting cells to provide a physical barrier to protect the cells from hostile extrinsic factors. Although the hydrogels significantly improve the therapeutic efficacy of transplanted cells, there have been no successful products commercialized based on these technologies. Recently, biomaterials are increasingly designed to provide cells with both a physical barrier and an extracellular matrix to further improve the secretion of therapeutic proteins from cells. This review will discuss (1) the cell encapsulation process, (2) the immunogenicity of the encapsulating hydrogel, (3) the transport properties of the hydrogel, (4) the hydrogel mechanical properties, and will propose new strategies to improve the hydrogel and cell interaction for successful cell-based drug delivery strategies.

[1]  P. de Vos,et al.  Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. , 2006, Biomaterials.

[2]  G Orive,et al.  Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  J. Kordower,et al.  Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons , 1994, The Journal of comparative neurology.

[4]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[5]  K. Anseth,et al.  The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. , 2007, Biomaterials.

[6]  R. Timpl,et al.  Local endostatin treatment of gliomas administered by microencapsulated producer cells , 2001, Nature Biotechnology.

[7]  Alan Dove,et al.  Cell-based therapies go live , 2002, Nature Biotechnology.

[8]  C. Heinzen,et al.  Quantitative study of the production and properties of alginate/poly-L-lysine microcapsules , 2002, Journal of microencapsulation.

[9]  P. Soon-Shiong,et al.  Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation , 1994, The Lancet.

[10]  S. Chang,et al.  Biocompatible microcapsules with enhanced mechanical strength. , 2002, Journal of biomedical materials research.

[11]  Jonathan Beck,et al.  Islet encapsulation: strategies to enhance islet cell functions. , 2007, Tissue engineering.

[12]  J. Hubbell,et al.  A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. , 1998, Biotechnology and bioengineering.

[13]  J. Hubbell,et al.  In Vitro and in Vivo Performance of Porcine Islets Encapsulated in Interfacially Photopolymerized Poly(Ethylene Glycol) Diacrylate Membranes , 1999, Cell transplantation.

[14]  J. Hubbell,et al.  Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. , 1998, Biomaterials.

[15]  J L West,et al.  Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. , 2001, Biomaterials.

[16]  L. Turka,et al.  The role of T-cell costimulatory activation pathways in transplant rejection. , 1998, The New England journal of medicine.

[17]  M. Tuszynski,et al.  Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury , 2003, Experimental Neurology.

[18]  Hideo Tanaka,et al.  Diffusion characteristics of substrates in Ca‐alginate gel beads , 1984, Biotechnology and bioengineering.

[19]  H. Auchincloss,et al.  Xenogeneic transplantation. , 1998, Annual review of immunology.

[20]  E. Opara,et al.  Characteristics of Poly-L-Ornithine-coated alginate microcapsules. , 2005, Biomaterials.

[21]  D. Mooney,et al.  The Effects of Poly(Ethyleneimine) (PEI) Molecular Weight on Reinforcement of Alginate Hydrogels , 2003, Cell transplantation.

[22]  S. Rafii,et al.  Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. , 2000, Experimental hematology.

[23]  M. Ferrari,et al.  Proteins and cells on PEG immobilized silicon surfaces. , 1998, Biomaterials.

[24]  Christopher C. Goodnow,et al.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.

[25]  Y. Bae,et al.  Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin. , 2004, Biomaterials.

[26]  G. Korbutt,et al.  Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. , 1999, Diabetes.

[27]  M. Goosen,et al.  Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas , 1985, Biotechnology and bioengineering.

[28]  J. A. Hubbell,et al.  Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. , 1992, Biomaterials.

[29]  K. Anseth,et al.  PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments. , 2006, Acta biomaterialia.

[30]  P. Vos,et al.  Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules , 1997 .

[31]  Gorka Orive,et al.  Drug delivery in biotechnology: present and future. , 2003, Current opinion in biotechnology.

[32]  Masataka Mori,et al.  Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Pedraz,et al.  Comparative study of microcapsules elaborated with three polycations (PLL, PDL, PLO) for cell immobilization , 2005, Journal of microencapsulation.

[34]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[35]  G. Klöck,et al.  Production of purified alginates suitable for use in immunoisolated transplantation , 2004, Applied Microbiology and Biotechnology.

[36]  A. Khademhosseini,et al.  Microscale technologies for tissue engineering and biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. A. Hubbell,et al.  Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. , 1994, Biotechnology and bioengineering.

[38]  Y. Tabata,et al.  Evaluation of Insulin Secretion of Isolated Rat Islets Cultured in Extracellular Matrix , 2001, Cell transplantation.

[39]  T. Ohnishi,et al.  Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain. , 1995, Cell transplantation.

[40]  David J Mooney,et al.  Quantifying the relation between adhesion ligand–receptor bond formation and cell phenotype , 2006, Proceedings of the National Academy of Sciences.

[41]  R. van Schilfgaarde,et al.  Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. , 2003, The Journal of surgical research.

[42]  P. Chang,et al.  Osmotic pressure test: a simple, quantitative method to assess the mechanical stability of alginate microcapsules. , 2001, Journal of biomedical materials research.

[43]  T. Chang,et al.  Secretion of Erythropoietin from Microencapsulated Rat Kidney Cells: Preliminary Results , 1993, The International journal of artificial organs.

[44]  Anne Simmons,et al.  The effect of charged groups on protein interactions with poly(HEMA) hydrogels. , 2006, Biomaterials.

[45]  David J. Mooney,et al.  Microenvironmental regulation of biomacromolecular therapies , 2007, Nature Reviews Drug Discovery.

[46]  P Aebischer,et al.  Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. , 2004, Human gene therapy.

[47]  J. A. Hubbell,et al.  Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. , 1993, Biomaterials.

[48]  Mohamed Al-Rubeai,et al.  Selection methods for high-producing mammalian cell lines. , 2007, Trends in biotechnology.

[49]  L. Yahia,et al.  Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. , 2006, Journal of biomedical materials research. Part A.

[50]  Catherine Picart,et al.  Buildup Mechanism for Poly(l-lysine)/Hyaluronic Acid Films onto a Solid Surface , 2001 .

[51]  Wee,et al.  Protein release from alginate matrices. , 1998, Advanced drug delivery reviews.

[52]  Anthony Atala,et al.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy , 2001, Nature Biotechnology.

[53]  M Rothmund,et al.  Parathyroid allotransplantation without immunosuppression , 1997, The Lancet.

[54]  T. Ohnishi,et al.  CELL THERAPY WITH ENCAPSULATED XENOGENEIC TUMOR CELLS SECRETING β-ENDORPHIN FOR TREATMENT OF PERIPHERAL PAIN. , 1995, Cell transplantation.

[55]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[56]  Hussila Keshaw,et al.  Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. , 2005, Biomaterials.

[57]  Eben Alsberg,et al.  FRET measurements of cell-traction forces and nano-scale clustering of adhesion ligands varied by substrate stiffness. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Ijima,et al.  Development of mammalian cell-enclosing subsieve-size agarose capsules (<100 microm) for cell therapy. , 2005, Biomaterials.

[59]  Timothy S. Weeks,et al.  Cohesive failure in partially cured epoxies , 1999 .

[60]  B. Halliwell.  Superoxide‐dependent formation of hydroxyl radicals in the presence of iron salts , 1978, FEBS letters.

[61]  D. Mooney,et al.  Designing alginate hydrogels to maintain viability of immobilized cells. , 2003, Biomaterials.

[62]  T. Kurokawa,et al.  Double‐Network Hydrogels with Extremely High Mechanical Strength , 2003 .

[63]  P Aebischer,et al.  Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.

[64]  J. Pedraz,et al.  Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. , 2006, Biomaterials.

[65]  T. Chang,et al.  Therapeutic applications of polymeric artificial cells , 2005, Nature Reviews Drug Discovery.

[66]  V. Kolb-Bachofen,et al.  Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes. , 1993, Transplantation.

[67]  Robert Langer,et al.  Micromolding of photocrosslinkable hyaluronic acid for cell encapsulation and entrapment. , 2006, Journal of biomedical materials research. Part A.

[68]  J. Tai,et al.  Assessment of the protective effect of uncoated alginate microspheres. , 1997, Transplantation proceedings.

[69]  P. de Vos,et al.  Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. , 1997, Biomaterials.

[70]  D. Mooney,et al.  Hydrogels for tissue engineering. , 2001, Chemical reviews.

[71]  J. Brash,et al.  Deterioration of polyamino acid-coated alginate microcapsules in vivo , 2002, Journal of biomaterials science. Polymer edition.

[72]  D. Mooney,et al.  Independent Control of Rigidity and Toughness of Polymeric Hydrogels , 2003 .

[73]  P Rolfe,et al.  Physical and biological properties of compound membranes incorporating a copolymer with a phosphorylcholine head group. , 1998, Biomaterials.

[74]  J. West,et al.  Endochondral Bone Formation from Hydrogel Carriers Loaded with BMP2-transduced Cells , 2007, Annals of Biomedical Engineering.

[75]  P. Tresco,et al.  Technology of mammalian cell encapsulation. , 2000, Advanced drug delivery reviews.

[76]  Xiaoyan Li,et al.  Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species* , 2004, Journal of Biological Chemistry.

[77]  J Mokrý,et al.  Biocompatibility of HEMA Copolymers Designed for Treatment of CNS Diseases with Polymer‐Encapsulated Cells , 2000, Biotechnology progress.